QUADRANT CAPITAL GROUP LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 181 filers reported holding NEKTAR THERAPEUTICS in Q4 2015. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2022$1,0000.0%409
+14.6%
0.00%
Q2 2022$1,000
-94.7%
357
-90.0%
0.00%
-100.0%
Q1 2022$19,000
+35.7%
3,572
+234.5%
0.00%0.0%
Q4 2021$14,000
+250.0%
1,068
+358.4%
0.00%
+100.0%
Q3 2021$4,000
+33.3%
233
+48.4%
0.00%
Q2 2021$3,0000.0%157
+1.9%
0.00%
Q1 2021$3,000
+50.0%
154
+28.3%
0.00%
Q4 2020$2,000
-60.0%
120
-59.3%
0.00%
-100.0%
Q3 2020$5,000
-44.4%
295
-22.4%
0.00%
-50.0%
Q2 2020$9,000
-62.5%
380
-73.2%
0.00%
-50.0%
Q1 2020$24,000
-14.3%
1,419
-3.7%
0.00%
+33.3%
Q4 2019$28,000
+27.3%
1,473
+12.5%
0.00%0.0%
Q3 2019$22,000
-68.1%
1,309
-34.6%
0.00%
-72.7%
Q2 2019$69,000
+1280.0%
2,002
+994.0%
0.01%
+1000.0%
Q1 2019$5,000
+25.0%
1830.0%0.00%0.0%
Q4 2018$4,000
-55.6%
183
+10.9%
0.00%
-66.7%
Q3 2018$9,000
-35.7%
165
-49.5%
0.00%
-40.0%
Q2 2018$14,000
-65.0%
327
-18.7%
0.01%
-66.7%
Q1 2018$40,000
+263.6%
402
+107.2%
0.02%
+275.0%
Q4 2017$11,000
+175.0%
1940.0%0.00%
+100.0%
Q3 2017$4,000194
+88.3%
0.00%
Q2 2017$0
-100.0%
1030.0%0.00%
-100.0%
Q1 2017$2,000
+100.0%
1030.0%0.00%0.0%
Q4 2016$1,0000.0%103
-11.2%
0.00%0.0%
Q3 2016$1,0000.0%1160.0%0.00%0.0%
Q2 2016$1,0000.0%1160.0%0.00%0.0%
Q1 2016$1,000
-83.3%
116
-68.0%
0.00%
-75.0%
Q4 2015$6,0003620.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2015
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 1,350,000$22,950,0001.87%
MAVERICK CAPITAL LTD 6,655,625$113,146,0001.81%
Camber Capital Management LP 2,500,000$42,500,0001.49%
Bellevue Group AG 3,866,258$65,726,0000.75%
Adero Partners, LLC 51,500$876,0000.75%
Goodman Financial Corp 108,342$1,842,0000.64%
CM Management, LLC 35,000$595,0000.55%
OSTERWEIS CAPITAL MANAGEMENT INC 424,504$7,217,0000.43%
RICE HALL JAMES & ASSOCIATES, LLC 568,379$9,662,0000.34%
Burleson & Company, LLC 107,736$1,832,0000.32%
View complete list of NEKTAR THERAPEUTICS shareholders